JP2002161043A - Skin care preparation - Google Patents

Skin care preparation

Info

Publication number
JP2002161043A
JP2002161043A JP2000402968A JP2000402968A JP2002161043A JP 2002161043 A JP2002161043 A JP 2002161043A JP 2000402968 A JP2000402968 A JP 2000402968A JP 2000402968 A JP2000402968 A JP 2000402968A JP 2002161043 A JP2002161043 A JP 2002161043A
Authority
JP
Japan
Prior art keywords
skin
effect
skin care
care preparation
evaluation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000402968A
Other languages
Japanese (ja)
Inventor
Atsushi Hirano
淳 平野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TS AASU KK
Original Assignee
TS AASU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TS AASU KK filed Critical TS AASU KK
Priority to JP2000402968A priority Critical patent/JP2002161043A/en
Publication of JP2002161043A publication Critical patent/JP2002161043A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a safe skin care preparation having normalizing effects on skin immunity and further having ameliorating effects on skin roughening, ameliorating effects on firmness and wrinkles of the skin and ameliorating effects on adhesion of makeup. SOLUTION: This skin care preparation comprises one or more kinds of extracts from a tuber of Harpagophytum procumbens and a thickened root of Lepidium meyenii W used therein.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は医薬品、医薬部外品
や化粧品などの皮膚外用剤に関するものである。さらに
詳しくはデビルズクロー、マカの1種以上の抽出物を含
む安全で有効な皮膚外用剤に関するものである。
The present invention relates to an external preparation for skin such as pharmaceuticals, quasi-drugs and cosmetics. More specifically, the present invention relates to a safe and effective external skin preparation containing one or more extracts of devil's claw and maca.

【0002】[0002]

【従来の技術】デビルズクローは学名Harpagop
hytum procumbensという植物の塊茎を
いう。この植物はアフリカの砂漠に分布するゴマ科の植
物で硬いトゲのある実ができることから、デビルズクロ
ーと呼ばれている。薬用植物として利用されている。
2. Description of the Related Art Devil's Claw has a scientific name of Harpagop.
Hytum procumbens refers to a tuber of a plant. This plant is a sesame plant distributed in the African desert and is called Devil's Claw because it has hard thorns. It is used as a medicinal plant.

【0003】マカは学名Lepidium meyen
ii Wという植物の肥大根をいう。この植物はペルー
北部山脈地帯の高山性植物であり、インディオの食料と
して栽培されている。薬用として、性欲増進や疲労回復
の目的で利用されている。
[0003] Maka is the scientific name Lepidium meyen
ii W refers to an enlarged root of a plant. This plant is an alpine plant in the Northern Peruvian Mountains and is cultivated as food for Indio. It is used as a medicinal product for the purpose of promoting libido and recovering from fatigue.

【0004】[0004]

【発明が解決しようとする課題】化粧品をはじめとする
皮膚外用剤は長期間に渡って連用されることがあり、皮
膚という面積の多い臓器に適用されるため、安全性は最
重視される項目の1つでまた、皮膚外用剤にとって必要
な有効性は様々にあり、皮膚の老化防止、肌荒れ防止な
どの効果が求められている。さらに皮膚の持つ機能は乾
燥した大気中でも生活出来るように体内からの水分を失
わないように保つことや外的な物理的な防御的な機能は
勿論あるが、最近の研究によって、皮膚は免疫に関して
も重要な役割を果たしていることがわかりつつある。皮
膚は、表皮の角化細胞、ランゲルハンス細胞、真皮の樹
状細胞、血管内皮細胞、マクロファージ等から構成され
ているが、外部からの異物としての抗原の進入に対し、
すみやかに接触して処理し、リンパ節へ移動してT細胞
にそれを提示し、以後の一連の免疫応答反応が始まると
考えられている。そして、紫外線を浴びることやストレ
スによってこの免疫機能が低下することもわかってお
り、発ガンに至らなくとも種々の皮膚疾患(疾患に至ら
ないものも含めて皮膚の異常)を発生させるおそれがあ
り皮膚免疫の正常化は充分考慮されるべき項目である。
さらにこの皮膚免疫の作用のみならず、肌荒れ改善効
果、肌のはり、シワ改善効果、化粧ののりの改善効果の
ある化粧品が求められている。
[0003] Skin external preparations such as cosmetics are often used for a long period of time, and are applied to organs having a large area such as the skin. In addition, there are various effects required for external preparations for skin, and effects such as prevention of skin aging and rough skin are required. In addition, the skin's functions include keeping the body from losing water so that it can live even in a dry atmosphere, and of course there are external physical defensive functions. Are also playing an important role. The skin is composed of epidermal keratinocytes, Langerhans cells, dermal dendritic cells, vascular endothelial cells, macrophages, etc.
It is believed that it is processed immediately upon contact, migrates to the lymph nodes and presents it to T cells, and a series of subsequent immune response reactions begins. It is also known that exposure to ultraviolet light and stress can reduce this immune function, and may cause various skin diseases (including those that do not lead to diseases) even if they do not lead to carcinogenesis. Normalization of skin immunity is an item that should be fully considered.
Further, there is a demand for cosmetics having not only the effect of skin immunity but also an effect of improving skin roughness, an effect of improving skin sticking, wrinkling, and an effect of improving makeup paste.

【0005】[0005]

【発明が解決するための手段】安全性と皮膚との有効性
を考え、鋭意検討した結果、デビルズクロー、マカの抽
出物を用いた皮膚外用剤が本発明の目的に最適なことが
判明した。デビルズクロー、マカの抽出物は皮膚免疫正
常化効果があり、さらに肌荒れ改善効果、肌のはり、シ
ワ改善効果、化粧ののりの改善効果があることがわかっ
た。これらの効果は皮膚免疫正常化効果だけが要因では
ないので、様々な作用が複合的に有用に働いていること
が考えられる。
Means for Solving the Problems As a result of intensive studies in consideration of safety and effectiveness with the skin, it has been found that an external preparation for skin using an extract of devil's claw and maca is most suitable for the purpose of the present invention. . It was found that the extracts of Devil's Claw and Maca have the effect of normalizing skin immunity, the effect of improving rough skin, the effect of improving skin sticking, wrinkles, and the effect of applying makeup. Since these effects are not solely due to the skin immunity normalizing effect, it is conceivable that various effects work in a complex and useful manner.

【0006】デビルズクロー、マカの抽出物の利用方法
は特に限定はないが、抽出物として利用する場合は、抽
出を容易にするため、必要によりミキサーなどで裁断、
粉砕する。これを水或いは親水性有機溶媒で抽出する。
用いる親水性有機溶媒はメタノール、エタノール、アセ
トン、グリセリン、1,3ブチレングリコール、プロピ
レングリコール等、あるいはこれらの混合物、あるいは
1種以上の親水性有機溶媒と水混合物で抽出する。しか
し、皮膚に適用する製剤であるので水やエタノールやグ
リセリンなど皮膚外用剤に用いても問題ない溶媒の方
が、溶媒の留去の必要性がなく利用範囲が広い。本発明
者らの実験では熱水抽出か低濃度の親水性有機溶媒水溶
液が好ましい。抽出条件は裁断の程度や目的、溶媒の種
類によって変化するが水のみの場合はかなり加温が可能
であり、100℃まで加温しても有効性の低下は有意に
低下することはない。溶媒の種類や皮膚外用剤の剤型に
よっては溶媒を1部あるいはすべてを留去する。これを
皮膚外用剤に配合する。
The method of using the devil's claw and maca extracts is not particularly limited, but when used as an extract, it is cut with a mixer or the like as necessary to facilitate the extraction.
Smash. This is extracted with water or a hydrophilic organic solvent.
The hydrophilic organic solvent used is extracted with methanol, ethanol, acetone, glycerin, 1,3 butylene glycol, propylene glycol, etc., or a mixture thereof, or a mixture of at least one hydrophilic organic solvent and water. However, since it is a preparation applied to the skin, a solvent which does not cause any problem even when used in an external preparation for skin such as water, ethanol, and glycerin has a wider range of use because there is no need to distill off the solvent. In our experiments, hot water extraction or a low concentration aqueous solution of a hydrophilic organic solvent is preferred. The extraction conditions vary depending on the degree of cutting, the purpose, and the type of the solvent, but when only water is used, considerable heating is possible, and even when the temperature is increased to 100 ° C., the effectiveness does not decrease significantly. One part or all of the solvent is distilled off depending on the type of the solvent and the dosage form of the external preparation for skin. This is mixed with a skin external preparation.

【0007】デビルズクロー、マカの抽出物を皮膚外用
剤に配合するが、抽出方法や配合目的などによって変化
するが、配合量は固形分として0.0001〜10.0
%が好ましい。また、他の配合する原料は限定されるこ
とはないので、自由に選択すればよいが、本発明の安全
で有効性のある皮膚外用剤という趣旨に反しない原料を
選択することは当然のことである。このため、美白や抗
酸化、細胞賦活(細胞老化防止)、保湿、肌荒れ防止及
びその改善等に効果のある各種の薬剤と併用することは
本発明の目的をさらに効果的にする。また、用途等によ
って、クリーム、乳液、ローション、パック、スプレ
ー、ジェル等任意の剤型より選択することはなんら問題
はない。
[0007] Devil's claw and maca extracts are blended into an external preparation for the skin. The amount varies depending on the extraction method and blending purpose, but the amount is 0.0001 to 10.0 as a solid content.
% Is preferred. In addition, since the other ingredients to be blended are not limited, they may be freely selected, but it is natural to select ingredients that do not contradict the purpose of the safe and effective external preparation for skin of the present invention. It is. For this reason, the use of various agents effective for whitening, antioxidation, cell activation (prevention of cell aging), moisturization, prevention of rough skin, and improvement thereof makes the object of the present invention more effective. In addition, there is no problem in selecting an arbitrary dosage form such as cream, milky lotion, lotion, pack, spray, gel and the like depending on the use and the like.

【0008】以下に実際の抽出方法の例である製造例と
製造例を配合した実施例を記載するが当然これらに限定
されることはない。
[0008] Hereinafter, a production example as an example of an actual extraction method and an example in which the production example is blended will be described. However, the present invention is not limited to these examples.

【0009】製造例−1 デビルズクロー(Harpagophytum pro
cumbensの塊茎の乾燥物)100gを細断した
後、精製水2kgを加えて、80℃まで加熱し、5時間
後、放冷したのち、濾紙で濾過後、濾液を減圧濃縮し
た。
Production Example-1 Devil's Claw (Harpagophytum pro)
After cutting 100 g of dried tubers of C.cumbs, 2 kg of purified water was added, heated to 80 ° C., cooled after 5 hours, filtered with filter paper, and the filtrate was concentrated under reduced pressure.

【0010】製造例−2 デビルズクロー(Harpagophytum pro
cumbensの塊茎の乾燥物)100gを細断した
後、精製水1kgとエタノール1kgを加えて、攪拌し
つつ10日間放置したのち、濾紙で濾過後、濾液を減圧
濃縮した。
Production Example-2 Devil's Claw (Harpagophytum pro)
After cutting 100 g of dried tubers of Cubens, 1 kg of purified water and 1 kg of ethanol were added, and the mixture was allowed to stand for 10 days with stirring. After filtration with filter paper, the filtrate was concentrated under reduced pressure.

【0011】製造例−3 マカ(Lepidium meyenii Wの肥大根
の乾燥物)100gを細断した後、精製水2kgを加え
て、80℃まで加熱し、5時間後、放冷したのち、濾紙
で濾過後、濾液を減圧濃縮した。
Production Example 3 After cutting 100 g of maca (dried radish of Lepidium meyenii W) into 100 g, 2 kg of purified water was added, heated to 80 ° C., and after 5 hours, allowed to cool and then filtered with filter paper. After filtration, the filtrate was concentrated under reduced pressure.

【0012】製造例−4 マカ(Lepidium meyenii Wの肥大根
の乾燥物))100gを細断した後、精製水1kgとエ
タノール1kgを加えて、攪拌しつつ10日間放置した
のち、濾紙で濾過後、濾液を減圧濃縮した。
Production Example-4 100 g of maca (dried radish of Lepidium meyenii W) was shredded, 1 kg of purified water and 1 kg of ethanol were added, and the mixture was allowed to stand with stirring for 10 days. The filtrate was concentrated under reduced pressure.

【0013】実施例は表1に示す処方で、A、Bともに
80℃で加温溶解し、BをAに撹拌しながら徐々に加え
乳化する。撹拌しながら冷却し35℃で撹拌を止め、放
置する方法でクリームを作成した。
In the examples, the formulations shown in Table 1 are used. Both A and B are heated and dissolved at 80 ° C., and B is gradually added to A while stirring to emulsify. The mixture was cooled with stirring, stopped stirring at 35 ° C., and left to prepare a cream.

【0014】 [0014]

【0015】効果を確認するため、以下の実験を行っ
た。 試験1 皮膚免疫機能回復試験 8週齢のC3H/HeN雄マウスを6群に分け、第1群
〜第5群のマウスの剃毛した腹部に、10mJ/cm
/日の紫外線を4日間連続照射した。1日目、2日目、
3日目、4日目の照射直後に、第1群〜第4群のマウス
の照射部位にそれぞれ製造例1〜4の2%液(溶媒は抽
出溶媒)を50μl/日塗布した。第5群のマウスの照
射部位には何も塗布しなかった。また第6群には紫外線
を照射しなかった。照射終了1日後に、照射部位(第6
群のマウスにおいては、第1群〜第5群のマウスの照射
部位と略同一の腹部)においてジニトロフルオロベンゼ
ン(DNFB)による接触アレルギー感作を行った。さ
らに感作の5日後に両耳介にて惹起し、さらにその1日
後に両耳介の腫脹の値(惹起の1日後の耳介の厚さから
惹起前の耳介の厚さを引いた値)を測定し、接触アレル
ギー反応の回復率(%)を次式により算出した。
The following experiment was conducted to confirm the effect. Test 1 Skin Immune Function Recovery Test Eight-week-old C3H / HeN male mice were divided into six groups, and 10 mJ / cm 2 was applied to the shaved abdomen of the mice of the first to fifth groups.
/ Day of UV irradiation for 4 consecutive days. Day 1, Day 2,
Immediately after the irradiation on the third day and the fourth day, 50 μl / day of a 2% solution (the solvent was an extraction solvent) of Production Examples 1 to 4 was applied to the irradiation sites of the mice in the first to fourth groups, respectively. Nothing was applied to the irradiated sites of the mice in the fifth group. The sixth group was not irradiated with ultraviolet rays. One day after the end of the irradiation, the irradiation site (No. 6)
In the mice of the group, contact allergy sensitization with dinitrofluorobenzene (DNFB) was performed on the abdomen (substantially the same as the irradiation site of the mice of the first to fifth groups). Further, 5 days after the sensitization, it was induced in both ears, and one day later, the swelling value of the both ears (the thickness of the pinna before the induction was subtracted from the thickness of the pinna one day after the induction) Was measured, and the recovery rate (%) of the contact allergic reaction was calculated by the following equation.

【0016】回復率=(a−b)×100/(c−b)Recovery rate = (ab) × 100 / (c−b)

【0017】ただし、aは第1群〜第4群の耳介腫脹の
値を、bは第5群の耳介腫脹の値を、cは第6群の耳介
腫脹の値を表す。結果を表2に示す。
Here, a represents the value of pinna swelling in the first to fourth groups, b represents the value of pinna swelling in the fifth group, and c represents the value of pinna swelling in the sixth group. Table 2 shows the results.

【0018】[0018]

【表2】 [Table 2]

【0019】試験2 人での有用性評価試験 18才から49才の女性ボランティア50名をランダム
に5群に分けた。右顔面に実施例、左顔面に比較例を1
日3回左右同量使用してもらった。(特に量の規定はし
なかった)3ヶ月後に肌の状態について以下の評価し
た。 2−1 剥離角層細胞試験 セロハンテープを皮膚に貼り、10秒後、ゆっくり剥が
し、これをヘマトキシン・エオシン染色を行い、以下の
判定基準で評価し、各群の平均値を算出し、結果を表3
に示す。 1.均一性 評価1 かなり不均一に角層が剥離している。 評価2 やや不均一に角層が剥離している。 評価3 極一部に不均一に角層が剥離している。 評価4 均一に角層が剥離している。 2.重層剥離度 評価1 かなり重層剥離が見られる。 評価2 やや重層剥離が見られる。 評価3 ほとんど重層剥離が見られない。 3.核残存性 評価1 かなり核が残存している。 評価2 やや核が残存している。 評価3 核が残存していない
Test for Evaluating the Usefulness of Two Tests Fifty female volunteers aged 18 to 49 were randomly divided into five groups. One example on the right face and one comparative example on the left face
The same amount was used three times a day. After 3 months (the amount was not specified), the following evaluation was performed on the condition of the skin. 2-1 Peeling stratum corneum cell test A cellophane tape was stuck on the skin, and after 10 seconds, it was slowly peeled off, stained with hematoxin / eosin, evaluated according to the following criteria, and the average value of each group was calculated. Table 3
Shown in 1. Uniformity evaluation 1 The stratum corneum has peeled off considerably unevenly. Evaluation 2 The stratum corneum was peeled off somewhat unevenly. Evaluation 3 The stratum corneum was peeled non-uniformly on an extremely small part. Evaluation 4 The stratum corneum was uniformly peeled. 2. Degree of multilayer peeling evaluation 1 A considerable degree of multilayer peeling is observed. Evaluation 2 Slightly delamination is observed. Evaluation 3 Almost no delamination was observed. 3. Nuclear survivability evaluation 1 Nuclear remains considerably. Evaluation 2 Some nuclear remains. Evaluation 3 No nuclear remains

【0020】[0020]

【表3】 [Table 3]

【0021】2−2 自覚的評価 以下の基準で、肌荒れ改善効果、肌のはり、シワ改善効
果、化粧ののりについて聞き取りした。結果を表4に示
す。(なお、試験期間中に皮膚の異常を訴えた人はいな
かった) 使用前に比較して非常に改善した 3 使用前に比較してに改善した 2 使用前に比較してややに改善した 1 使用前と変化なし 0 使用前に比較して悪化した −1 使用前に比較してに悪化した −2 使用前に比較して非常に悪化した −3
2-2 Subjective evaluation The following criteria were used to hear about the effect of improving skin roughness, the effect of reducing skin swelling and wrinkles, and the effect of applying makeup. Table 4 shows the results. (There was no person who complained of abnormal skin during the test period) Very improved compared to before use 3 Improved compared to before use 2 Improved slightly compared to before use 1 Use No change compared to before 0 Deteriorated compared to before use -1 Degraded compared to before use -2 Very deteriorated compared to before use -3

【0022】[0022]

【表4】 [Table 4]

【0023】[0023]

【発明の効果】本発明上記の試験より皮膚免疫の機能を
回復し、正常化する機能を有し、また、実際にデビルズ
クロー、マカの1種以上の抽出物を用いた皮膚外用剤は
肌荒れ改善効果、肌のはり、シワ改善効果、化粧ののり
が改善し、皮膚外用剤として有効性の高いことがわかっ
た。また、古くより食用とされ、安全性も全く問題ない
ことは言うまでもない。
The present invention has the function of restoring and normalizing the function of skin immunity from the above test, and the skin preparation for external use using one or more extracts of devil's claw and maca is actually rough. The improvement effect, skin swelling, wrinkle amelioration effect, and cosmetic sizing were improved, and it was found that the skin external preparation was highly effective. Needless to say, it has been considered edible since ancient times and has no problem with safety.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】デビルズクロー、マカの1種以上の抽出物
を用いた皮膚外用剤
An external preparation for skin using at least one extract of devil's claw and maca.
JP2000402968A 2000-11-27 2000-11-27 Skin care preparation Pending JP2002161043A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000402968A JP2002161043A (en) 2000-11-27 2000-11-27 Skin care preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000402968A JP2002161043A (en) 2000-11-27 2000-11-27 Skin care preparation

Publications (1)

Publication Number Publication Date
JP2002161043A true JP2002161043A (en) 2002-06-04

Family

ID=18867165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000402968A Pending JP2002161043A (en) 2000-11-27 2000-11-27 Skin care preparation

Country Status (1)

Country Link
JP (1) JP2002161043A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072684A1 (en) * 2004-01-28 2005-08-11 Suntory Limited Process for producing maca extract
WO2006117464A1 (en) * 2005-04-29 2006-11-09 Laboratoire Nuxe Skin protective composition based on araucaria grain extracts
FR2885300A1 (en) * 2005-05-04 2006-11-10 Nuxe Sa Lab Topical cosmetic and/or dermatological composition useful for skin protection comprises an araucaria seed extract
JP2007254344A (en) * 2006-03-23 2007-10-04 Naris Cosmetics Co Ltd Maillard reaction inhibitor, skin care preparation containing the same and food and beverage
JP2009132634A (en) * 2007-11-29 2009-06-18 Nippon Menaade Keshohin Kk Antiobestic agent
US10806790B1 (en) * 2013-11-12 2020-10-20 Scott Shapiro Pain therapy cream with deep tissue delivery system

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072684A1 (en) * 2004-01-28 2005-08-11 Suntory Limited Process for producing maca extract
WO2006117464A1 (en) * 2005-04-29 2006-11-09 Laboratoire Nuxe Skin protective composition based on araucaria grain extracts
FR2885300A1 (en) * 2005-05-04 2006-11-10 Nuxe Sa Lab Topical cosmetic and/or dermatological composition useful for skin protection comprises an araucaria seed extract
JP2007254344A (en) * 2006-03-23 2007-10-04 Naris Cosmetics Co Ltd Maillard reaction inhibitor, skin care preparation containing the same and food and beverage
JP2009132634A (en) * 2007-11-29 2009-06-18 Nippon Menaade Keshohin Kk Antiobestic agent
US10806790B1 (en) * 2013-11-12 2020-10-20 Scott Shapiro Pain therapy cream with deep tissue delivery system

Similar Documents

Publication Publication Date Title
JPH09328410A (en) Cosmetic and its production
CN113332160A (en) Cosmetic composition for conditioning peritrichotic skin
JP2000128765A (en) Skin cosmetic
JPS61271210A (en) Cosmetic
KR101525876B1 (en) Method for making glue from donkey skin and cosmetics containing the same
JPH0611686B2 (en) Cosmetics
JP2002161043A (en) Skin care preparation
JP2001131049A (en) Skin preparation for external use
JPH10158181A (en) Lipolysis promoter and skin cosmetic for weight reduction
JPH0692292B2 (en) Cosmetics
JP2010184916A (en) Hair growth promoter
JP2003160497A (en) Skin care preparation
JPH06336422A (en) External agent for skin
JPH0899860A (en) Skin external agent
KR20090087223A (en) Cosmetic composition for pore-minimizing containing limonia acidissima extract
JP2000212058A (en) Skin cosmetic, active oxygen eliminator, esterase inhibitor, and collagenase inhibitor
JPH11171784A (en) External preparation for skin
JP2002161044A (en) Skin care preparation
JPH07145033A (en) Cosmetic for prevention of dermal aging
KR20170001201A (en) A cosmetic composition containing carrot leaf extract
JP2002363093A (en) Skin care preparation
JPH10147537A (en) Immunological function improving agent
JP3367621B2 (en) Cosmetic for wrinkle improvement
JPS61236713A (en) Skin cosmetic
KR20040079051A (en) Topical constituents of ginsenoside Rh2 and ginsenoside Rg3